Active ingredient
Tolvaptan
24 finished FDA listings contain Tolvaptan as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- TOLVAPTAN
- Dosage forms
- Tablet
- Routes
- Oral
- Manufacturers / labelers
- 8
- Strengths listed
- 15 mg/1 · 30 mg/1 · 45 mg/1 · 60 mg/1 · 90 mg/1
- Brand names in FDA listings
- Jynarque, Samsca
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 358257
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 022275 | OTSUKA | 2009-05-19 | 2 |
| NDA 204441 | OTSUKA | 2018-04-23 | 2 |
| ANDA 211891 | ALKEM LABS LTD | 2020-05-19 | 3 |
| ANDA 207605 | APOTEX | 2020-05-19 | 2 |
| ANDA 205646 | HETERO LABS LTD V | 2021-07-16 | 2 |
| ANDA 206119 | PH HEALTH | 2022-02-15 | 2 |
| ANDA 216949 | MSN | 2023-06-21 | 4 |
| ANDA 216063 | LUPIN | 2025-04-23 | 2 |
| ANDA 220147 | ALKEM LABS LTD | 2026-04-21 | 5 |
Official labeling on DailyMed
- TOLVAPTAN TABLET TOLVAPTAN KIT [ASCEND LABORATORIES, LLC] · version 6 · 2026-09-03
- TOLVAPTAN TABLET [PAR HEALTH USA, LLC] · version 9 · 2026-08-20
- SAMSCA (TOLVAPTAN) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] · version 23 · 2026-06-01
- TOLVAPTAN TABLET [NORTHSTAR RX LLC] · version 3 · 2026-04-27
- JYNARQUE (TOLVAPTAN) KIT JYNARQUE (TOLVAPTAN) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] · version 19 · 2025-11-17
- TOLVAPTAN ( TOLVAPTAN ) KIT TOLVAPTAN TABLET [LUPIN PHARMACEUTICALS, INC.] · version 6 · 2025-05-13
- TOLVAPTAN TABLET [NOVADOZ PHARMACEUTICALS LLC] · version 1 · 2023-10-04
- TOLVAPTAN TABLET [ASCEND LABORATORIES, LLC] · version 10 · 2022-09-09
- TOLVAPTAN (TOLVAPTAN) TABLET [CAMBER PHARMACEUTICALS, INC.] · version 2 · 2022-09-06
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.